The loudness dependence auditory evoked potential is insensitive to acute changes in serotonergic and noradrenergic neurotransmission

Human Psychopharmacology

Volumn 25, Issue 5, 2010, Pages 423-427

  Oliva, Jessica ^a   Leung, Sumie ^b   Croft, Rodney J ^c   O'Neill, Barry V ^d   O'Kane, Joanne ^b   Stout, Julie ^a   Phan, K Luan ^e   Nathan, Pradeep J ^a,d  

^a MONASH UNIVERSITY   (Australia)

^b SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

^c UNIVERSITY OF WOLLONGONG   (Australia)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Biological marker; Electrophysiology; Healthy participants; LDAEP; Noradrenaline; Serotonin

Indexed keywords

CITALOPRAM; PLACEBO; REBOXETINE; SEROTONIN; ADRENERGIC RECEPTOR AFFECTING AGENT; MORPHOLINE DERIVATIVE; NORADRENALIN; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EVOKED AUDITORY RESPONSE; FEMALE; HUMAN; LOUDNESS; MALE; NEUROTRANSMISSION; NORADRENERGIC SYSTEM; PHARMACODYNAMICS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROTONINERGIC SYSTEM; ADOLESCENT; DRUG EFFECTS; ELECTROPHYSIOLOGY; HEARING; METABOLISM; YOUNG ADULT;

ADOLESCENT; ADRENERGIC UPTAKE INHIBITORS; ADULT; CITALOPRAM; DOUBLE-BLIND METHOD; ELECTROPHYSIOLOGICAL PHENOMENA; EVOKED POTENTIALS, AUDITORY; FEMALE; HUMANS; LOUDNESS PERCEPTION; MALE; MORPHOLINES; NOREPINEPHRINE; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; YOUNG ADULT;

EID: 77955765749     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.1133     Document Type: Article

References (32)

1. Baribeau JC, Laurent JP. 1987. The effect of selective attention on augmenting/ intensity function of the early negative waves of AEPs. Electroencephalogr Clin Neurophysiol Suppl 40: 68-75.
2. Buchsbaum M, Pfefferbaum A. 1971. Individual differences in stimulus intensity response. Psychophysiology 8: 600-611.
3. Campbell MJ, Lewis DA, Foote SL, Morrison JH. 1987. Distribution of choline acetyltransferase-, serotonin-, dopamine-beta-hydroxylase-, tyrosine hydroxylase-immunoreactive fibers in monkey primary auditory cortex. J Comp Neurol 261: 209-220.
4. Camposano S, Lolas F. 1992. Effects of stimulation intensity, gender and handedness upon auditory evoked potentials. Arq Neuropsiquiatr 50: 43-49.
5. Croft RJ, Barry RJ. 2000. EOG correction of blinks with saccade coefficients: a test and revision of the aligned artefact average solution. Clin Neurophysiol 111: 444-451.
6. Dierks T, Barta S, Demisch L, et al. 1999. Intensity dependence of auditory evoked potentials (AEPs) as biological marker for cerebral serotonin levels: effects of tryptophan depletion in healthy subjects. Psychopharmacology 146: 101-107. (Pubitemid 29441120)
7. Dostert P, Benedetti MS, Poggesi I. 1997. Review of the pharmacokinetics and metabolism of reboxetine, a selective noradrenaline reuptake inhibitor. Eur Neuropsychopharmacol 7: S23-S35. (Pubitemid 27240333)
8. Guille V, Croft RJ, O'Neill BV, Illic S, Phan KL, Nathan PJ. 2008. An examination of acute changes in serotonergic neurotransmission using the loudness dependence measure of auditory cortex evoked activity: effects of citalopram, escitalopram and sertraline. Hum Psychopharmacol 23: 231-241. (Pubitemid 351577693)
9. Hegerl U, Gallinat J, Mrowinski D. 1994. Intensity dependence of auditory evoked dipole source activity. Int J Psychophysiol 17: 1-13. (Pubitemid 24217848)
10. Hegerl U, Juckel G. 1993. Intensity dependence of auditory evoked potentials as an indicator of central serotonergic neurotransmission: a new hypothesis. Biol Psychiatry 33(3): 173-187. (Pubitemid 23089966)
11. Hyttel J. 1994. Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs). Int Clin Psychopharmacol 9(Suppl 1): 19-26. (Pubitemid 24107713)
12. Juckel G, Gallinat J, Riedel M, et al. 2003. Serotonergic dysfunction in schizophrenia assessed by the loudness dependence measure of primary auditory cortex evoked activity. Schizophr Res 64: 115-124. (Pubitemid 37412333)
13. Juckel G, Hegerl U, Molnar M, Csepe V, Karmos G. 1999. Auditory evoked potentials reflect serotonergic neuronal activity - a study in behaving cats administered drugs acting on 5-HT1A autoreceptors acting in the dorsal raphe nucleus. Neuropsychopharmacology 21: 710-716.
14. Juckel G, Molnar M, Hegerl U, Csepe V, Karmos G. 1997. Auditory evoked potentials as indicator of brain serotonergic activity - first evidence in behaving cats. Biol Psychiatry 41: 1181-1195. (Pubitemid 27237179)
15. Juckel G, Pogarell O, Augustin H, et al. 2007. Differential prediction of first clinical response to serotonergic and noradrenergic antidepressants using the loudness dependence of auditory evoked potentials in patients with major depressive disorder. J Clil Psychiatr 68: 1206-1212. (Pubitemid 47395622)
16. Kähkönen S, Jääskeläinen IP, Pennanen S, Liesivuori J, Ahveninen J. 2002. Acute tryptophan depletion decreases intensity dependence of auditory evoked magnetic N1/P2 dipole source activity. Psychopharmacology 164: 221-227. (Pubitemid 36015587)
17. Kemp AH, Gray MA, Silberstein RB, Armstrong SM, Nathan PJ. 2004. Augmentation of serotonin enhances pleasant and suppresses unpleasant cortical electrophysiological responses to visual emotional stimuli in humans. Neuroimage 22(3): 1084-1096.
18. Laruelle M, Kegeles LS, Abi-Dargham A. 2003. Glutamate, dopamine, and schizophrenia: from pathophysiology to treatment. Ann N Y Acad Sci 1003: 138-158. (Pubitemid 38083052)
19. Linka T, Sartory G, Wiltfang J, Muller BW. 2009. Treatment effects of serotonergic and noradrenergic antidepressants on the intensity dependence of auditory ERP components in major depression. Neurosci Lett 463: 26-30.
20. Nathan PJ, Segrave R, Phan KL, O'Neill B, Croft RJ. 2006. Direct evidence that acutely enhancing serotonin with the selective serotonin reuptake inhibitor citalopram modulates the loudness dependence of the auditory evoked potential (LDAEP) marker of central serotonin function. Hum Psychopharmacol 21(1): 47-52. (Pubitemid 43192475)
21. Norra C, Becker S, Brocheler A, Kawohl W, Kunert HJ, Buchner H. 2008. Loudness dependence of evoked dipole source activity during acute serotonin challenge in females. Hum Psychopharmacol 23: 31-42. (Pubitemid 351166066)
22. Norra C, Mrazek M, Tuchtenhagen F, et al. 2003. Enhanced intensity dependence as a marker of low serotonergic neurotransmission in borderline personality disorder. J Psychiatr Res 37: 23-33. (Pubitemid 35449768)
23. O'Neill BV, Croft RJ, Leung S, et al. 2006. Dopamine receptor stimulation does not modulate the loudness dependence of the auditory evoked potential in humans. Psychopharmacology 188(1): 92-99. (Pubitemid 44268245)
24. O'Neill BV, Croft RJ, Leung S, Oliver C, Phan KL, Nathan PJ. 2007. High-dose glycine inhibits the loudness dependence of the auditory evoked potential (LDAEP) in healthy humans. Psychopharmacology (Berl) 195(1): 85-93. (Pubitemid 47568619)
25. O'Neill BV, Guille V, Croft RJ, et al. 2008a. Effects of selective and combined serotonin and dopamine depletion on the loudness dependence of the auditory evoked potential (LDAEP) in humans. Hum Psychopharmacol 23: 301-312. (Pubitemid 351982667)
26. O'Neill BV, Croft RJ, Nathan PJ. 2008b. The loudness dependence of the auditory evoked potential (LDAEP) as an in vivo biomarker of central serotonergic function in humans: rationale, evaluation and review of findings. Hum Psychopharmacol 23: 355-370.
27. Sanacora G, Zarate CA, Krystal JH, Manji HK. 2008. Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nat Rev Drug Discov 7(5): 426-437. (Pubitemid 351619114)
28. Senkowski D, Linden M, Zubragel D, Bar T, Gallinat J. 2003. Evidence for disturbed cortical signal processing and altered serotonergic neurotransmission in generalized anxiety disorder. Biol Psychiatry 53: 304-314. (Pubitemid 36175544)
29. Tabachnick B, Fidell L. 2007. Using Multivariate Statistics. Pearson Education: New Jersey.
30. Uhl I, Gorynia I, Gallinat J, et al. 2006. Is the loudness dependence of auditory evoked potentials modulated by the selective serotonin reuptake inhibitor citalopram in healthy subjects? Hum Psychopharmacol 21(7): 463-471.
31. Von Knorring L, Perris C. 1981. Biochemistry of the augmenting/reducing response in visual evoked potentials. Neuropsychobiology 7: 1-8. (Pubitemid 11241332)
32. Wang W, Wang YH, Fu XM, Sun ZM, Schoenen J. 1999. Auditory evoked potentials and multiple personality measures in migraine and post-traumatic headaches. Pain 79: 235-242. (Pubitemid 29076758)